Month: September 2024

Danske Bank CFO to retire. New CFO appointed

Written by Customer Service on September 2, 2024. Posted in Public Companies.

Company announcement no 38 2024 Danske Bank A/SBernstorffsgade 40DK – 1577 København VTel. +45 45 14 00 00 2 September 2024Danske Bank CFO to retire. New CFO appointed After dedicating almost five years to Danske Bank and a total of 36 years to an active business career, Stephan Engels, who is the Chief Financial Officer and a member of the Executive Leadership Team in Danske Bank, has decided to retire from executive leadership roles. He has decided to announce his retirement early to allow for a good transition of leadership, remaining in his role at Danske Bank until 1 March 2025. “I am grateful for the opportunity to have been a part of Danske Bank over the past years, but all good things come to an end. I am confident that when the time comes next year, I will be able to pass the baton to competent leadership and a strong...

Invalda INVL informs that the purchase of own shares is starting

Written by Customer Service on September 2, 2024. Posted in Public Companies.

Invalda INVL informs that the purchase of the company’s own shares, which was announced on 5 July 2024 (the notification on material event), starts on 2 September through the market of official offer of Nasdaq Vilnius stock exchange. The purchase conditions remain unchanged:Share purchase starts on 2 September 2024.Share purchase ends on 6 September 2024.The maximum number of shares to be purchased is 67,430 units.Maximum purchase price is EUR 1 million (one million euros).The maximum purchase price of shares is EUR 14.83 per share (value of consolidated equity per share as of 31 December 2023).The purchase price of the shares shall be determined by the Dutch auction principle, i.e. transactions shall be executed at a single price. The person authorised to provide additional information: Darius Šulnis CEO of Invalda INVL E-mail ...

Sword Group : 1st step in German-speaking Switzerland

Written by Customer Service on September 2, 2024. Posted in Mergers And Acquisitions.

The Group acquired INCOR, a company based in Bern! INCOR is a Bern-based company specialising in Digital Transformation. INCOR has developed digital know-how on long-term projects mainly dedicated to the Government Institutions of the Swiss Confederation. INCOR’s current turnover trend is CHF6 million, with an EBITDA margin of 8%, which should increase from 2025. This company will be consolidated in the Group’s accounts from 1 July 2024. This acquisition is fully in line with the announced strategy of establishing a presence in German-speaking Switzerland. At its financial meeting on 11 September, the Group will present the accelerators in its strategic plan. To attend this meeting and find out all the latest Sword news, please register here. About Sword Group Sword has 3,000+ IT/Digital specialists active in 50+ countries to accompany...

Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to show reduction in disability accumulation in non-relapsing secondary progressive multiple sclerosis

Written by Customer Service on September 2, 2024. Posted in Public Companies.

Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to show reduction in disability accumulation in non-relapsing secondary progressive multiple sclerosisIn the HERCULES study, tolebrutinib met the primary endpoint in delaying time to onset of confirmed disability progression in people with nrSPMS, a population for which there are currently no approved therapies and significant unmet medical need The GEMINI 1 and 2 studies evaluating tolebrutinib in people with relapsing MS (RMS) did not show significance in the primary endpoint of reducing annualized relapse rate over Aubagio (teriflunomide). Analysis of the key secondary endpoint of pooled 6-month confirmed disability worsening (CDW) data showed a considerable delay in time to onset Phase 3 study results will form the basis for future discussions with...

Golar LNG Limited – Fixed income investor meetings

Written by Customer Service on September 2, 2024. Posted in Public Companies.

Golar LNG Limited (“Golar”) has mandated DNB Markets and Pareto Securities as Global Coordinators and Joint Bookrunners, and Clarksons Securities and Fearnley Securities as Joint Bookrunners, to arrange a series of fixed income investor meetings commencing Monday 2 September 2024. A new USD denominated 5-year senior unsecured fixed rate bond issue may follow, subject to inter alia market conditions. The net proceeds from the contemplated bond issue are to be applied for capital expenditure and/or refinancing of debt and general corporate purposes. About Golar LNG Golar LNG is a NASDAQ listed maritime LNG infrastructure company. Through its 75-year history, the company has pioneered maritime LNG infrastructure including the world’s first Floating LNG liquefaction terminal (FLNG) and Floating Storage and Regasification Unit (FSRU)...

Hepsor AS Subsidiary to Build a Wooden Apartment Building in Central Tallinn

Written by Customer Service on September 2, 2024. Posted in Public Companies.

Hepsor V7 OÜ, a subsidiary of Hepsor AS, acquired a property in the heart of Tallinn, at Võistluse 7, where it is planned to build a unique environmentally friendly wooden apartment building. A four-story apartment building is planned for development. The project is based on the sLender-type apartment building concept created by researchers and architects from the Estonian Academy of Arts, inspired by the early 20th-century Lender wooden house style. The building will be constructed entirely from wood, except for the stairwell in the center. The project focuses on environmental protection and includes green technological solutions that enhance climate resilience. “Hepsor is committed to creating innovative and sustainable solutions, building unique and high-quality residential and commercial buildings. The construction of Estonia’s...

Nxera Pharma to Receive US$35 Million from Neurocrine Biosciences upon Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568

Written by Customer Service on September 2, 2024. Posted in Public Companies.

Tokyo, Japan and Cambridge, UK, 2 September 2024 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – announces that it will receive a US$35 million payment from Neurocrine Biosciences (‘Neurocrine’), triggered by the successful completion of the Phase 2 trial with NBI-1117568 (NBI-‘568) in adults with schizophrenia, as announced on 28 August 2024. Receipt of the US$35 million payment will be recognized as one-time revenue in the third quarter of 2024. The NBI-’568-SCZ2028 dose-finding study met its primary endpoint for the once-daily 20 mg dose and was generally safe and well tolerated at all doses studied, supporting Neurocrine’s intentions to advance NBI-‘568 into Phase 3 clinical trials in early 2025. Please refer to “Nxera Pharma Notes Positive Phase 2 Data for Partnered...

PickleJar Debuts Nationwide Jackson Dean Fan Experience Contest With Big Machine Records

Written by Customer Service on September 1, 2024. Posted in Public Companies.

PickleJar Entertainment Group, Inc.PickleJar Contest – Jackson Dean at Red RocksHOUSTON, Sept. 01, 2024 (GLOBE NEWSWIRE) — PickleJar Entertainment Group, (OTCMKTS: PKLE), a leading Texas-based music and entertainment software company, announced today the launch of a nationwide flyaway contest with Cumulus Media and sponsored by Big Machine Records. From September 1, 2024 through September 16, 2024, PickleJar Fans will have a chance to win the Grand Prize for a winner and their guest to see Jackson Dean make his debut appearance at the legendary Red Rocks Amphitheater in Morrison, Colorado on October 12, 2024. “Jackson Dean has been a friend of the show from the very start. What better way to celebrate his Red Rocks debut by sending two lucky listeners to Colorado to share in the experience!” said Patrick Thomas,...

iRhythm Technologies Announces Results of GUARD-AF Trial

Written by Customer Service on September 1, 2024. Posted in Public Companies.

GUARD-AF trial results presented at European Society of Cardiology (ESC) Congress 2024 Leveraging iRhythm’s Zio® patch-based long-term continuous monitoring (LTCM), GUARD-AF is the largest randomized trial in a primary care setting to evaluate the impact of screening for undiagnosed atrial fibrillation (AF) Screening with iRhythm’s Zio® XT1 LTCM led to increase in new diagnosis of AF (5.0% vs 3.3%) over an average follow-up of 15 months. No difference in stroke hospitalization vs usual care in the context of reduced statistical power due to truncated enrollment and follow-up.SAN FRANCISCO, Sept. 01, 2024 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the presentation and publication...

Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer

Written by Customer Service on September 1, 2024. Posted in Public Companies.

Dr. Scholl is a globally recognized leader in the field of ophthalmology and the coordinating principal investigator of the largest ever natural history study of Stargardt diseaseSAN DIEGO, Sept. 01, 2024 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that its board of directors has appointed Hendrik P. N. Scholl, MD, MA, as the Chief Medical Officer of the Company, effective immediately. Dr. Scholl is the foremost globally recognized authority on Stargardt disease and age-related macular degeneration (AMD), bringing decades of expertise in treating retinal diseases, including the two key indications...

Month: September 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals